LEADER 02751nam 22009013u 450 001 9910972032203321 005 20240416172505.0 010 $a9782742012343 010 $a2742012346 035 $a(CKB)3710000000025020 035 $a(EBL)3317898 035 $a(SSID)ssj0001048635 035 $a(PQKBManifestationID)12381905 035 $a(PQKBTitleCode)TC0001048635 035 $a(PQKBWorkID)11017933 035 $a(PQKB)11028185 035 $a(PPN)185797083 035 $a(FR-PaCSA)88821148 035 $a(MiAaPQ)EBC3317898 035 $a(FRCYB88821148)88821148 035 $a(EXLCZ)993710000000025020 100 $a20151005d2014|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aOrphan Drugs in Epilepsy 205 $a1st ed. 210 $aMontrouge $cJOHN LIBBEY EUROTEXT$d2014 215 $a1 online resource (90 p.) 225 1 $aTopics in Epilepsy ;$vv.4 300 $aDescription based upon print version of record. 311 08$a9782742008100 311 08$a2742008101 327 $a""Orphan Drugs in Epilepsy""; ""Contents""; ""Foreword""; ""Bromides""; ""Adrenocorticotropic hormone and corticosteroids""; ""Stiripentol""; ""Felbamate""; ""Rufinamide"" 410 0$aTopics in Epilepsy 606 $aEpilepsy -- Treatment 606 $aBrain Diseases 606 $aCentral Nervous System Agents 606 $aDrug Industry 606 $aIndustry 606 $aTherapeutic Uses 606 $aCentral Nervous System Diseases 606 $aNervous System Diseases 606 $aTechnology, Industry, and Agriculture 606 $aPharmacologic Actions 606 $aChemical Actions and Uses 606 $aDisease 606 $aAnticonvulsants 606 $aEpilepsy 606 $aOrphan Drug Production 615 4$aEpilepsy -- Treatment. 615 2$aBrain Diseases. 615 2$aCentral Nervous System Agents. 615 2$aDrug Industry. 615 2$aIndustry. 615 2$aTherapeutic Uses. 615 2$aCentral Nervous System Diseases. 615 2$aNervous System Diseases. 615 2$aTechnology, Industry, and Agriculture. 615 2$aPharmacologic Actions. 615 2$aChemical Actions and Uses. 615 2$aDisease. 615 2$aAnticonvulsants. 615 2$aEpilepsy. 615 2$aOrphan Drug Production. 676 $a616.853 700 $aNikanorova$b Marina$01796203 701 $aJohannessen$b Svein I$01796204 701 $aGenton$b Pierre$01679223 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910972032203321 996 $aOrphan Drugs in Epilepsy$94337874 997 $aUNINA